| ST003365 Intracellular and medium metabolomics for BT-474 breast cancer cells treated with a range of Fasnall and GSK2194069 concentrations for 24 h | ||||
| Limit by pathway class: | ||||
| ST003365 Intracellular and medium metabolomics for BT-474 breast cancer cells treated with a range of Fasnall and GSK2194069 concentrations for 24 h | ||||
| Limit by pathway class: | ||||
|